104869-26-3

104869-26-3 structure

Name: NF 157
Chemical Name: ctk8e6694
CAS Number: 104869-26-3
Molecular Formula: C₄₉H₂₈F₂N₆Na₆O₂₃S₆
Molecular Weight: 1437.10000
Catalog: Signaling Pathways GPCR/G Protein P2Y Receptor
Create Date: 2017-11-11 09:34:07
Modify Date: 2024-04-06 14:02:48
NF157 is a highly selective nanomolar P2Y11 antagonist with a pKi of 7.35. The IC50s are 463 nM, 1811 µM, 170 µM for P2Y11 (Ki=44.3 nM), P2Y1 (Ki=187 µM), P2Y2 (Ki=28.9 µM), respectively[1]. NF157, significantly reduces expression of metalloproteinase (MMP)-3, MMP-13, can be used in the treatment of osteoarthritis (OA)[2].

Name	ctk8e6694
Synonyms	nf 157

Description	NF157 is a highly selective nanomolar P2Y11 antagonist with a pKi of 7.35. The IC50s are 463 nM, 1811 µM, 170 µM for P2Y11 (Ki=44.3 nM), P2Y1 (Ki=187 µM), P2Y2 (Ki=28.9 µM), respectively[1]. NF157, significantly reduces expression of metalloproteinase (MMP)-3, MMP-13, can be used in the treatment of osteoarthritis (OA)[2].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> P2Y Receptor Research Areas >> Inflammation/Immunology
Target	pKi: 7.35 (P2Y11)[1] IC50: 463 nM (P2Y11), 1811 µM (P2Y1), 170 µM (P2Y2)[1] Ki: 44.3 nM (P2Y11), 187 µM (P2Y1), 28.9 µM (P2Y2)[1]
In Vitro	NF157 displays selectivity for P2Y11 over P2Y1 (>650-fold), P2Y2 (>650-fold), P2X2 (3-fold), P2X3 (8-fold), P2X4 (>22-fold), and P2X7 (>67-fold) but no selectivity over P2X1[1]. NF157 (30 and 60 µM; 24 hours) causes a significant reduction in degradation of type II collagen in a dose-dependent manner. 60 µM NF157 nearly completely rescues type II collagen from degradation induced by TNF-α (10 ng/mL)[2]. NF157 (30 and 60 µM; 24 hours) almost fully restores nuclear translocation of p65 triggered by TNF-α (10 ng/mL) and significantly reduces the luciferase activity of NF-κB[2]. Western Blot Analysis[2] Cell Line: SW1353 cells Concentration: 30 and 60 µM Incubation Time: 24 hours Result: Ameliorated TNF-α-induced degradation of type II collagen. Western Blot Analysis[2] Cell Line: SW1353 cells Concentration: 30 and 60 µM Incubation Time: 24 hours Result: Reduced TNF-α-induced activation of NF-κB.
References	[1]. Ullmann H, et al. Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency. J Med Chem. 2005 Nov 3;48(22):7040-8. [2]. Wang D, et al. Inhibition of P2Y11R ameliorated TNF-α-induced degradation of extracellular matrix in human chondrocytic SW1353 cells. Am J Transl Res. 2019 Apr 15;11(4):2108-2116.

Molecular Formula	C₄₉H₂₈F₂N₆Na₆O₂₃S₆
Molecular Weight	1437.10000
Exact Mass	1435.89000
PSA	551.01000
LogP	11.27180

104869-26-3	25433-85-6
104869-24-1	104869-38-7
1443449-07-7	1821386-63-3
111150-22-2	51415-04-4
3795-88-8	2419107-97-2
1340151-16-7	1341416-99-6
1408730-12-0	934548-21-7
1488931-16-3	1466572-63-3
1495736-29-2	1477800-93-3
1483788-72-2	1483547-92-7